A detailed history of Alps Advisors Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 2,957 shares of TMO stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,957
Previous 1,213 143.78%
Holding current value
$1.52 Million
Previous $670,000 172.84%
% of portfolio
0.01%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$531.86 - $624.21 $927,563 - $1.09 Million
1,744 Added 143.78%
2,957 $1.83 Million
Q2 2024

Aug 13, 2024

SELL
$541.52 - $599.02 $66,606 - $73,679
-123 Reduced 9.21%
1,213 $670,000
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $30,671 - $34,766
58 Added 4.54%
1,336 $776,000
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $30,198 - $37,305
70 Added 5.79%
1,278 $678,000
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $658,739 - $759,370
-1,322 Reduced 52.25%
1,208 $611,000
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $1.33 Million - $1.55 Million
-2,620 Reduced 50.87%
2,530 $1.32 Million
Q1 2023

May 10, 2023

SELL
$535.0 - $604.82 $318,325 - $359,867
-595 Reduced 10.36%
5,150 $2.97 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $231,206 - $272,543
-477 Reduced 7.67%
5,745 $3.16 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $1.37 Million - $1.64 Million
-2,709 Reduced 30.33%
6,222 $3.16 Million
Q2 2022

Aug 11, 2022

BUY
$500.9 - $612.21 $931,674 - $1.14 Million
1,860 Added 26.3%
8,931 $4.85 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $64,976 - $79,970
-124 Reduced 1.72%
7,071 $4.18 Million
Q4 2021

Feb 09, 2022

BUY
$569.0 - $667.24 $56,331 - $66,056
99 Added 1.4%
7,195 $4.8 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $134,006 - $160,372
-263 Reduced 3.57%
7,096 $4.05 Million
Q2 2021

Aug 11, 2021

BUY
$441.0 - $508.24 $427,770 - $492,992
970 Added 15.18%
7,359 $3.71 Million
Q1 2021

May 07, 2021

BUY
$439.85 - $518.83 $554,650 - $654,244
1,261 Added 24.59%
6,389 $2.92 Million
Q4 2020

Feb 03, 2021

SELL
$435.06 - $527.66 $85,706 - $103,949
-197 Reduced 3.7%
5,128 $2.39 Million
Q3 2020

Nov 05, 2020

SELL
$359.77 - $441.52 $701 Million - $861 Million
-1,949,575 Reduced 99.73%
5,325 $2.35 Million
Q3 2020

Nov 04, 2020

BUY
$359.77 - $441.52 $703 Million - $863 Million
1,954,221 Added 287808.69%
1,954,900 $1.63 Million
Q2 2020

Aug 05, 2020

SELL
$275.2 - $362.34 $21,465 - $28,262
-78 Reduced 10.3%
679 $246,000
Q1 2020

May 06, 2020

SELL
$255.3 - $340.05 $1.43 Million - $1.91 Million
-5,611 Reduced 88.11%
757 $215,000
Q4 2019

Feb 07, 2020

SELL
$271.93 - $328.04 $69,342 - $83,650
-255 Reduced 3.85%
6,368 $2.07 Million
Q3 2019

Nov 04, 2019

BUY
$268.46 - $305.43 $260,943 - $296,877
972 Added 17.2%
6,623 $1.93 Million
Q2 2019

Aug 07, 2019

SELL
$257.51 - $295.55 $295,363 - $338,995
-1,147 Reduced 16.87%
5,651 $1.66 Million
Q1 2019

May 01, 2019

SELL
$212.17 - $273.72 $1.4 Million - $1.8 Million
-6,577 Reduced 49.17%
6,798 $1.86 Million
Q4 2018

Feb 04, 2019

BUY
$208.47 - $251.98 $381,708 - $461,375
1,831 Added 15.86%
13,375 $2.99 Million
Q3 2018

Oct 25, 2018

BUY
$205.57 - $244.32 $2.37 Million - $2.82 Million
11,544 New
11,544 $2.82 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.